🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Penile Cancer

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma NCT07110038Phase 29 sites📍 Dresden📍 Düsseldorf📍 Mainz Institut für Klinische Krebsforschung IKF GmbH at Krankenha… · Tests: Avelumab, enfortumab vedotin Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer NCT06353906Phase 22 sites📍 Leuven📍 Amsterdam The Netherlands Cancer Institute · Tests: Carboplatin/Paclitaxel, Pembrolizumab, Partial or total penectomy with inguinal and/or pelvic lymph node dissection Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... NCT06161532Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Sacituzumab govitecan, Atezolizumab QL1706 Plus Lenvatinib in Previously Treated Penile Cancer NCT07384416Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: QL1706 + Lenvatinib DEfeating PEnile CAncer-2 NCT07378670NA9 sites📍 Berlin📍 Dresden📍 Erlangen University Hospital Tuebingen · Tests: open inguinal lymphadenectomy, robot-assisted inguinal lymphadenectomy Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies NCT04923178n/a1 site📍 Bethesda National Cancer Institute (NCI) Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma NCT05526989Phase 22 sites📍 Tampa📍 Houston H. Lee Moffitt Cancer Center and Research Institute · Tests: Dostarlimab, Niraparib Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors NCT06684327Phase 21 site📍 Shanghai Fudan University · Tests: Albumin-paclitaxel Injection FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer NCT05999396Phase 11 site📍 Tübingen German Cancer Research Center · Tests: Administration of CC-3 Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers NCT06717711Phase 32 sites📍 Rome📍 Naples Regina Elena Cancer Institute · Tests: Low-intensity Extracorporeal Shock Wave Therapy (LiESWT), PDE5 inhibitor (tadalafil) A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer NCT07497919Phase 21 site📍 Shanghai Fudan University · Tests: Becotatug Vedotin (recombinant humanized anti-EGFR mAb-MMAE conjugate) combined with Pucotenlimab (recombinant humanize… The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma NCT05447273n/a1 site📍 Oslo Oslo University Hospital · Tests: Multi-parametric, functional magnetic resonance imaging (MRI) MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma NCT07054307Phase 11 site📍 Chengdu Jiyan Liu · Tests: MRG003, HX008 Lymphedema After Urologic Surgery NCT05264337n/a2 sites📍 Gothenburg📍 Örebro Vastra Gotaland Region · Tests: Self-reported lymphedema, Dielectric constant ratio, Limb volume Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis NCT06104618Phase 23 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Enfortumab Vedotin, Computed Tomography, Magnetic Resonance Imaging Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors NCT03866382Phase 2582 sites📍 Birmingham📍 Anchorage📍 Anchorage National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Scan, Cabozantinib S-malate, Computed Tomography, Echocardiography Test Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate NCT01601171n/a1 site📍 Lausanne Centre Hospitalier Universitaire Vaudois E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972Phase 1, Phase 22 sites📍 New Brunswick📍 New Brunswick Christian Hinrichs · Tests: E7 TCR-T cells, Aldesleukin Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846Phase 21 site📍 Shanghai Fudan University · Tests: Ivocizumab E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226Phase 23 sites📍 Bethesda📍 New Brunswick📍 New Brunswick Christian Hinrichs · Tests: E7 TCR-T cells, Aldesleukin SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720Phase 11 site📍 Qingdao The Affiliated Hospital of Qingdao University · Tests: SCG142 TCR-T cells At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites📍 Jacksonville📍 Grand Forks Mayo Clinic · Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration HRYZ-T101 Injection for HPV18 Positive Solid Tumor NCT05952947Phase 11 site📍 Shanghai HRYZ Biotech Co. · Tests: HRYZ-T101 Injection, Fludarabine + Cyclophosphamide A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas NCT07217171Phase 116 sites📍 Duarte📍 Los Angeles📍 San Francisco EvolveImmune United, Inc · Tests: EVOLVE104, EVOLVE104 EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer NCT07518979Phase 21 site📍 Chengdu Jiyan Liu · Tests: Becotatug Vedotin, Pucotenlimab PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II) NCT06875258Phase 43 sites📍 Nijmegen📍 Amsterdam📍 Rotterdam The Netherlands Cancer Institute · Tests: Sildenafil, Erectile vacuum device
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy